Displaying 1 - 9 of 9
Last updated : 19 April 2024 02:50

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

Authors (67)
Cancer Cell
Published
Crick labs/ facilities
Full details

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

Authors (64)
Cell Reports Medicine
Published
Crick labs/ facilities
Full details

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

Authors (62)
The Lancet
Published
Crick labs/ facilities
Full details

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

Authors (65)
Cancer Cell
Published
Crick labs/ facilities
Full details

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Authors (98)
Nature Cancer
Published
Crick labs/ facilities
Full details

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Authors (98)
Nature Cancer
Published
Crick labs/ facilities
Full details

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Authors (89)
Nature Cancer
Published
Crick labs/ facilities
Full details

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Authors (341)
The Lancet
Published
Crick labs/ facilities
Full details